Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 55/100

Failure Rate

20.0%

1 terminated/withdrawn out of 5 trials

Success Rate

75.0%

-11.5% vs industry average

Late-Stage Pipeline

40%

2 trials in Phase 3/4

Results Transparency

33%

1 of 3 completed trials have results

Key Signals

1 with results

Enrollment Performance

Analytics

Phase 4
2(100.0%)
2Total
Phase 4(2)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (5)

Showing 5 of 5 trials
NCT01007474Withdrawn

One Hospital ClinicalService Project

Role: lead

NCT01290952Phase 4Completed

On Versus Off Pump Myocardial Revascularization Study

Role: lead

NCT01216670Completed

Cardiac Rhythm Monitoring After Acute Decompensation for Heart Failure

Role: lead

NCT01109641Phase 4Completed

PhrenIc Nerve mappinG and Stimulation EP Catheter Study: PING-EP Study

Role: lead

NCT00873899Unknown

Evolution of Management Strategies of Heart Failure Patients With Implantable Defibrillators

Role: collaborator

All 5 trials loaded